Literature DB >> 8175394

Large animal normal tissue tolerance with boron neutron capture.

P R Gavin1, S L Kraft, C E DeHaan, C D Swartz, M L Griebenow.   

Abstract

PURPOSE: Normal tissue tolerance of boron neutron capture irradiation using borocaptate sodium (NA2B12H11SH) in an epithermal neutron beam was studied. METHODS AND MATERIALS: Large retriever-type dogs were used and the irradiations were performed by single dose, 5 x 10 dorsal portal. Fourteen dogs were irradiated with the epithermal neutron beam alone and 35 dogs were irradiated following intravenous administration of borocaptate sodium.
RESULTS: Total body irradiation effect could be seen from the decreased leukocytes and platelets following irradiation. Most values returned to normal within 40 days postirradiation. Severe dermal necrosis occurred in animals given 15 Gy epithermal neutrons alone and in animals irradiated to a total peak physical dose greater than 64 Gy in animals following borocaptate sodium infusion. Lethal brain necrosis was seen in animals receiving between 27 and 39 Gy. Lethal brain necrosis occurred at 22-36 weeks postirradiation. A total peak physical dose of approximately 27 Gy and blood-boron concentrations of 25-50 ppm resulted in abnormal magnetic resonance imaging results in 6 months postexamination. Seven of eight of these animals remained normal and the lesions were not detected at the 12-month postirradiation examination.
CONCLUSION: The bimodal therapy presents a complex challenge in attempting to achieve dose response assays. The resultant total radiation dose is a composite of low and high LET components. The short track length of the boron fission fragments and the geometric effect of the vessels causes much of the intravascular dose to miss the presumed critical target of the endothelial cells. The results indicate a large dose-sparing effect from the boron capture reactions within the blood.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175394     DOI: 10.1016/0360-3016(94)90483-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Allogeneic astrocytoma in immune competent dogs.

Authors:  M E Berens; A Giese; J R Shapiro; S W Coons
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

Review 2.  A review: CNS effects and normal tissue tolerance in dogs.

Authors:  P R Gavin; S L Kraft; R Huiskamp; J A Coderre
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

3.  A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease.

Authors:  Paul M Busse; Otto K Harling; Matthew R Palmer; W S Kiger; Jody Kaplan; Irving Kaplan; Cynthia F Chuang; J Tim Goorley; Kent J Riley; Thomas H Newton; Gustavo A Santa Cruz; Xing-Qi Lu; Robert G Zamenhof
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

4.  In Vivo Accelerator-Based Boron Neutron Capture Therapy for Spontaneous Tumors in Large Animals: Case Series.

Authors:  Vladimir Kanygin; Aleksandr Kichigin; Alexander Zaboronok; Anna Kasatova; Elena Petrova; Alphiya Tsygankova; Evgenii Zavjalov; Bryan J Mathis; Sergey Taskaev
Journal:  Biology (Basel)       Date:  2022-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.